Clarified Precision Medicine
Daniel Rotroff is a highly experienced professional in the fields of medicine, bioinformatics, and computational research. Currently serving as Associate Staff and Director at the Cleveland Clinic's Center for Quantitative Metabolic Research, Daniel focuses on innovative research in type 2 diabetes and obesity. Additional roles include Chief Medical Information Officer at Genovation Health, Chief Technology Officer at Clarified Precision Medicine, and member of the Board of Directors at My Bluem. Daniel has an academic appointment as an Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine and has previously held leadership positions in bioinformatics and computational toxicology. Daniel's academic background includes a Ph.D. and a Master's degree in Environmental Science and Engineering from the University of North Carolina at Chapel Hill, complemented by a Bachelor's degree in Biological Sciences from North Carolina State University.
This person is not in any teams
Clarified Precision Medicine
Clarified Precision Medicine is the first scalable molecular tumor board with a combination of AI-based platform plus medical group, offering expert clinical somatic and pharmacogenomics consultations through its ClarifiedSelect™ and OncoGuardian™ solutions. Clarified accelerates the delivery of guidelines-based genomic insights to patients and providers by bringing together nationally recognized experts in medical oncology, oncology pharmacy, data integration, and molecular pathology who have over 100 years of collective experience in the application of precision oncology. For more information, visit: www.clarifiedprecisionmedicine.com